Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Joko

Showing results (11-20 of 15) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 15 results.
Hinyokika Kiyo. Acta Urologica Japonica|June 1, 1993
[Clinical study of sonography and percutaneous nephrostomy in pyonephrosis]K Ishizu, T Wada, M Yamamoto, et al.
Clinical Radiology|November 18, 2021
A validation study of combined resection and ablation therapy for multiple hepatocellular carcinomaT Tada, T Kumada, H Toyoda, et al.
Journal of Viral Hepatitis|February 16, 2017
Hepatitis B surface antigen reduction by switching from long-term nucleoside/nucleotide analogue administration to pegylated interferonN Tamaki, M Kurosaki, A Kusakabe, et al.
ESMO Open|November 30, 2021
Nonalcoholic steatohepatitis in hepatocarcinoma: new insights about its prognostic role in patients treated with lenvatinibM Rimini, M Kudo, T Tada, et al.
ESMO Open|October 8, 2022
Atezolizumab plus bevacizumab versus lenvatinib or sorafenib in non-viral unresectable hepatocellular carcinoma: an international propensity score matching analysisM Rimini, L Rimassa, K Ueshima, et al.
Pageof 2

Showing results (11-20 of 15) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 15 results.
Hinyokika Kiyo. Acta Urologica Japonica|June 1, 1993
[Clinical study of sonography and percutaneous nephrostomy in pyonephrosis]K Ishizu, T Wada, M Yamamoto, et al.
Clinical Radiology|November 18, 2021
A validation study of combined resection and ablation therapy for multiple hepatocellular carcinomaT Tada, T Kumada, H Toyoda, et al.
Journal of Viral Hepatitis|February 16, 2017
Hepatitis B surface antigen reduction by switching from long-term nucleoside/nucleotide analogue administration to pegylated interferonN Tamaki, M Kurosaki, A Kusakabe, et al.
ESMO Open|November 30, 2021
Nonalcoholic steatohepatitis in hepatocarcinoma: new insights about its prognostic role in patients treated with lenvatinibM Rimini, M Kudo, T Tada, et al.
ESMO Open|October 8, 2022
Atezolizumab plus bevacizumab versus lenvatinib or sorafenib in non-viral unresectable hepatocellular carcinoma: an international propensity score matching analysisM Rimini, L Rimassa, K Ueshima, et al.
Pageof 2